Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations

Kazuhiko Nakamura, Chih Ken Chen, Yoshimoto Sekine, Yasuhide Iwata, A. Anitha, El Wui Loh, Nori Takei, Atsuko Suzuki, Masayoshi Kawai, Kiyokazu Takebayashi, Katsuaki Suzuki, Yoshio Minabe, Kenji Tsuchiya, Kazuo Yamada, Masaomi Iyo, Norio Ozaki, Toshiya Inada, Nakao Iwata, Mutsuo Harano, Tokutaro KomiyamaMitsuhiko Yamada, Ichiro Sora, Hiroshi Ujike, David M. Ball, Takeo Yoshikawa, Shih Ku Lin, Norio Mori

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

SOD2 (superoxide dismutase 2) plays a crucial role in protecting the cells against damage caused by free radicals, by catalyzing their detoxification. On the other hand, cell damage caused by free radical generation following methamphetamine administration has been postulated as one of the possible pathophysiological mechanisms for methamphetamine psychosis. Hence, we investigated the association of SOD2 polymorphisms with the development of methamphetamine psychosis, in two independent populations of Japan and Taiwan. We recruited 116 patients with methamphetamine psychosis and 189 controls in Japan, and 135 patients with methamphetamine psychosis and 204 controls in Taiwan. The methamphetamine group was divided into two clinical subtypes: a transient type of psychosis (i.e., good prognosis) and a prolonged type of psychosis (i.e., poor prognosis), according to the course of the manifestation of psychosis. With reference to the genotypic and allelic frequencies of Ala/Val functional polymorphism in exon 2, we found significant differences between individuals with prolonged methamphetamine psychosis and control samples from Japan and Taiwan in the genotypic (P value 0.014 and 0.016, respectively) and in the allelic (P value 0.004 and 0.047, respectively) frequencies. Our results suggest that Ala/Val polymorphism of the SOD2 gene could be associated with the risk of developing methamphetamine psychosis.

Original languageEnglish
Pages (from-to)243-252
Number of pages10
JournalHuman Genetics
Volume120
Issue number2
DOIs
Publication statusPublished - Sep 1 2006
Externally publishedYes

Fingerprint

Methamphetamine
Psychotic Disorders
Population
Taiwan
Japan
Free Radicals
superoxide dismutase 2
Individuality
Exons

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations. / Nakamura, Kazuhiko; Chen, Chih Ken; Sekine, Yoshimoto; Iwata, Yasuhide; Anitha, A.; Loh, El Wui; Takei, Nori; Suzuki, Atsuko; Kawai, Masayoshi; Takebayashi, Kiyokazu; Suzuki, Katsuaki; Minabe, Yoshio; Tsuchiya, Kenji; Yamada, Kazuo; Iyo, Masaomi; Ozaki, Norio; Inada, Toshiya; Iwata, Nakao; Harano, Mutsuo; Komiyama, Tokutaro; Yamada, Mitsuhiko; Sora, Ichiro; Ujike, Hiroshi; Ball, David M.; Yoshikawa, Takeo; Lin, Shih Ku; Mori, Norio.

In: Human Genetics, Vol. 120, No. 2, 01.09.2006, p. 243-252.

Research output: Contribution to journalArticle

Nakamura, K, Chen, CK, Sekine, Y, Iwata, Y, Anitha, A, Loh, EW, Takei, N, Suzuki, A, Kawai, M, Takebayashi, K, Suzuki, K, Minabe, Y, Tsuchiya, K, Yamada, K, Iyo, M, Ozaki, N, Inada, T, Iwata, N, Harano, M, Komiyama, T, Yamada, M, Sora, I, Ujike, H, Ball, DM, Yoshikawa, T, Lin, SK & Mori, N 2006, 'Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations', Human Genetics, vol. 120, no. 2, pp. 243-252. https://doi.org/10.1007/s00439-006-0189-y
Nakamura, Kazuhiko ; Chen, Chih Ken ; Sekine, Yoshimoto ; Iwata, Yasuhide ; Anitha, A. ; Loh, El Wui ; Takei, Nori ; Suzuki, Atsuko ; Kawai, Masayoshi ; Takebayashi, Kiyokazu ; Suzuki, Katsuaki ; Minabe, Yoshio ; Tsuchiya, Kenji ; Yamada, Kazuo ; Iyo, Masaomi ; Ozaki, Norio ; Inada, Toshiya ; Iwata, Nakao ; Harano, Mutsuo ; Komiyama, Tokutaro ; Yamada, Mitsuhiko ; Sora, Ichiro ; Ujike, Hiroshi ; Ball, David M. ; Yoshikawa, Takeo ; Lin, Shih Ku ; Mori, Norio. / Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations. In: Human Genetics. 2006 ; Vol. 120, No. 2. pp. 243-252.
@article{db4b0d2df266457fa1bd36c331d93409,
title = "Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations",
abstract = "SOD2 (superoxide dismutase 2) plays a crucial role in protecting the cells against damage caused by free radicals, by catalyzing their detoxification. On the other hand, cell damage caused by free radical generation following methamphetamine administration has been postulated as one of the possible pathophysiological mechanisms for methamphetamine psychosis. Hence, we investigated the association of SOD2 polymorphisms with the development of methamphetamine psychosis, in two independent populations of Japan and Taiwan. We recruited 116 patients with methamphetamine psychosis and 189 controls in Japan, and 135 patients with methamphetamine psychosis and 204 controls in Taiwan. The methamphetamine group was divided into two clinical subtypes: a transient type of psychosis (i.e., good prognosis) and a prolonged type of psychosis (i.e., poor prognosis), according to the course of the manifestation of psychosis. With reference to the genotypic and allelic frequencies of Ala/Val functional polymorphism in exon 2, we found significant differences between individuals with prolonged methamphetamine psychosis and control samples from Japan and Taiwan in the genotypic (P value 0.014 and 0.016, respectively) and in the allelic (P value 0.004 and 0.047, respectively) frequencies. Our results suggest that Ala/Val polymorphism of the SOD2 gene could be associated with the risk of developing methamphetamine psychosis.",
author = "Kazuhiko Nakamura and Chen, {Chih Ken} and Yoshimoto Sekine and Yasuhide Iwata and A. Anitha and Loh, {El Wui} and Nori Takei and Atsuko Suzuki and Masayoshi Kawai and Kiyokazu Takebayashi and Katsuaki Suzuki and Yoshio Minabe and Kenji Tsuchiya and Kazuo Yamada and Masaomi Iyo and Norio Ozaki and Toshiya Inada and Nakao Iwata and Mutsuo Harano and Tokutaro Komiyama and Mitsuhiko Yamada and Ichiro Sora and Hiroshi Ujike and Ball, {David M.} and Takeo Yoshikawa and Lin, {Shih Ku} and Norio Mori",
year = "2006",
month = "9",
day = "1",
doi = "10.1007/s00439-006-0189-y",
language = "English",
volume = "120",
pages = "243--252",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations

AU - Nakamura, Kazuhiko

AU - Chen, Chih Ken

AU - Sekine, Yoshimoto

AU - Iwata, Yasuhide

AU - Anitha, A.

AU - Loh, El Wui

AU - Takei, Nori

AU - Suzuki, Atsuko

AU - Kawai, Masayoshi

AU - Takebayashi, Kiyokazu

AU - Suzuki, Katsuaki

AU - Minabe, Yoshio

AU - Tsuchiya, Kenji

AU - Yamada, Kazuo

AU - Iyo, Masaomi

AU - Ozaki, Norio

AU - Inada, Toshiya

AU - Iwata, Nakao

AU - Harano, Mutsuo

AU - Komiyama, Tokutaro

AU - Yamada, Mitsuhiko

AU - Sora, Ichiro

AU - Ujike, Hiroshi

AU - Ball, David M.

AU - Yoshikawa, Takeo

AU - Lin, Shih Ku

AU - Mori, Norio

PY - 2006/9/1

Y1 - 2006/9/1

N2 - SOD2 (superoxide dismutase 2) plays a crucial role in protecting the cells against damage caused by free radicals, by catalyzing their detoxification. On the other hand, cell damage caused by free radical generation following methamphetamine administration has been postulated as one of the possible pathophysiological mechanisms for methamphetamine psychosis. Hence, we investigated the association of SOD2 polymorphisms with the development of methamphetamine psychosis, in two independent populations of Japan and Taiwan. We recruited 116 patients with methamphetamine psychosis and 189 controls in Japan, and 135 patients with methamphetamine psychosis and 204 controls in Taiwan. The methamphetamine group was divided into two clinical subtypes: a transient type of psychosis (i.e., good prognosis) and a prolonged type of psychosis (i.e., poor prognosis), according to the course of the manifestation of psychosis. With reference to the genotypic and allelic frequencies of Ala/Val functional polymorphism in exon 2, we found significant differences between individuals with prolonged methamphetamine psychosis and control samples from Japan and Taiwan in the genotypic (P value 0.014 and 0.016, respectively) and in the allelic (P value 0.004 and 0.047, respectively) frequencies. Our results suggest that Ala/Val polymorphism of the SOD2 gene could be associated with the risk of developing methamphetamine psychosis.

AB - SOD2 (superoxide dismutase 2) plays a crucial role in protecting the cells against damage caused by free radicals, by catalyzing their detoxification. On the other hand, cell damage caused by free radical generation following methamphetamine administration has been postulated as one of the possible pathophysiological mechanisms for methamphetamine psychosis. Hence, we investigated the association of SOD2 polymorphisms with the development of methamphetamine psychosis, in two independent populations of Japan and Taiwan. We recruited 116 patients with methamphetamine psychosis and 189 controls in Japan, and 135 patients with methamphetamine psychosis and 204 controls in Taiwan. The methamphetamine group was divided into two clinical subtypes: a transient type of psychosis (i.e., good prognosis) and a prolonged type of psychosis (i.e., poor prognosis), according to the course of the manifestation of psychosis. With reference to the genotypic and allelic frequencies of Ala/Val functional polymorphism in exon 2, we found significant differences between individuals with prolonged methamphetamine psychosis and control samples from Japan and Taiwan in the genotypic (P value 0.014 and 0.016, respectively) and in the allelic (P value 0.004 and 0.047, respectively) frequencies. Our results suggest that Ala/Val polymorphism of the SOD2 gene could be associated with the risk of developing methamphetamine psychosis.

UR - http://www.scopus.com/inward/record.url?scp=33746995982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746995982&partnerID=8YFLogxK

U2 - 10.1007/s00439-006-0189-y

DO - 10.1007/s00439-006-0189-y

M3 - Article

C2 - 16807759

AN - SCOPUS:33746995982

VL - 120

SP - 243

EP - 252

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 2

ER -